Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natacha Bordry

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Vaccines|August 26, 2023
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant RecipientsNatacha Bordry, Anne-Claire Mamez, Chiara Fedeli, et al.
Iscience|January 3, 2022
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancerNatacha Bordry, Alfredo Addeo, Cyril Jaksic, et al.
Cancer Cell|July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerAlfredo Addeo, Pankil K Shah, Natacha Bordry, et al.
Science Translational Medicine|April 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockadeNatalie J Neubert, Martina Schmittnaegel, Natacha Bordry, et al.
Oncoimmunology|September 18, 2018
Lymphatic vessel density is associated with CD8Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Vaccines|August 26, 2023
SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant RecipientsNatacha Bordry, Anne-Claire Mamez, Chiara Fedeli, et al.
Iscience|January 3, 2022
Humoral and cellular immunogenicity two months after SARS-CoV-2 messenger RNA vaccines in patients with cancerNatacha Bordry, Alfredo Addeo, Cyril Jaksic, et al.
Cancer Cell|July 2, 2021
Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerAlfredo Addeo, Pankil K Shah, Natacha Bordry, et al.
Science Translational Medicine|April 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockadeNatalie J Neubert, Martina Schmittnaegel, Natacha Bordry, et al.
Oncoimmunology|September 18, 2018
Lymphatic vessel density is associated with CD8Natacha Bordry, Maria A S Broggi, Kaat de Jonge, et al.
Pageof 2